Rezultati - Lyubomir T. Vassilev
- Showing 1 - 20 results of 32
- Go to Next Page
-
1
-
2
-
3
Targeting the p53–MDM2 interaction to treat cancer od Christian Klein, Lyubomir T. Vassilev
Izdano 2004Revisão -
4
-
5
-
6
-
7
-
8
-
9
-
10
-
11
Emetine allows identification of origins of mammalian DNA replication by imbalanced DNA synthesis, not through conservative nucleosome segregation. od William C. Burhans, Lyubomir T. Vassilev, Jiarui Wu, José M. Sogo, Ferez S. Nallaseth, Melvin L. DePamphilis
Izdano 1991Artigo -
12
-
13
-
14
-
15
-
16
-
17
-
18
-
19
A New Class of Selective ATM Inhibitors as Combination Partners of DNA Double-Strand Break Inducing Cancer Therapies od Astrid Zimmermann, Frank T. Zenke, Li-Ya Chiu, Heike Dahmen, Ulrich Pehl, Thomas Fuchß, Thomas Grombacher, Beatrix Blume, Lyubomir T. Vassilev, Andree Blaukat
Izdano 2022Artigo -
20
Pharmacologic Inhibitor of DNA-PK, M3814, Potentiates Radiotherapy and Regresses Human Tumors in Mouse Models od Frank T. Zenke, Astrid Zimmermann, Christian Sirrenberg, Heike Dahmen, Vladimir Kirkin, Ulrich Pehl, Thomas Grombacher, Claudia Wilm, Thomas Fuchß, Christiane Amendt, Lyubomir T. Vassilev, Andree Blaukat
Izdano 2020Artigo
Iskalna orodja:
Sorodne teme
Biology
Cancer research
Apoptosis
Genetics
Biochemistry
Cell biology
Chemistry
Mdm2
Cancer
Cancer cell
Cell cycle
Gene
DNA
Medicine
Pharmacology
Cell cycle checkpoint
Programmed cell death
Internal medicine
Molecular biology
DNA damage
Cell culture
Cyclin-dependent kinase 1
DNA repair
DNA replication
Immunology
Small molecule
Suppressor
Carcinogenesis
In vitro
In vivo